Skip to content
Clinical Trials – home
Therapeutic area

Nervous system disorders – page 26

  • 1 389 clinical trials
  • 585 recruiting
  • 453 conditions
  • 29 countries

Conditions in this area

453 conditions with trials, the busiest first

Clinical trials in Nervous system disorders

1 389 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

1 389 clinical trials

Study of Satralizumab for Children with Neuromyelitis Optica Spectrum Disorder (NMOSD)

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Satralizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer's, Parkinson's, or ALS Using Dronabinol and Cannabidiol

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cannabidiol
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita

Study on the Effects of Botulinum Toxin Type A and a Drug Combination on Rectal Function in Patients with Fecal Incontinence

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Centre Hospitalier Universitaire Rouen

Neoplasm+2

Recruiting

Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apl-101
  • Sponsor:Apollomics Inc.

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Vibegron
  • Sponsor:Sumitomo Pharma America Inc.

Study on the Safety of EDV2209 for Patients with Brain Bleeding (Subarachnoid Hemorrhage)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:1,4-Diamino-2,3-Dicyano-1,4-Bis(O-Aminophenylmercapto)Butadiene Hemiethanolate
  • Sponsor:Edvince AB

Migraine

Recruiting

Study on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Study of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study of tovorafenib (DAY101) in children and young adults aged 6 months to 25 years with brain tumors and other solid tumors that have RAF gene changes

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Tovorafenib
  • Sponsor:Day One Biopharmaceuticals Inc.

PET/CT Imaging Study for Patients with Giant Cell Arteritis or Rheumatoid Arthritis Using Zirconium (89Zr) Crefmirlimab Berdoxam

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Zirconium (89Zr) Crefmirlimab Berdoxam
  • Sponsor:Universitair Medisch Centrum Groningen

Anaesthesia+1

Recruiting

Study on Pain Relief Using Serratus Plane Block with Ropivacaine, Lidocaine Hydrochloride, and Dexamethasone Sodium Phosphate for Intensive Care Patients Undergoing Pleural Drainage

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ropivacaine
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Study on Riluzole for Reducing Spasticity in Patients with Chronic Spinal Cord Injury

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Riluzole
  • Sponsor:Centre Hospitalier Regional De Marseille

Substances studied in this area

The therapies tested most often in Nervous system disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.